SCHEMBL2069726

SCHEMBL2069726

CCCOC(=O)Nc1ccc(N)cc1C

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.59
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
MAPT P10636 1/20 0.51
KDR P35968 3/20 0.51
EGFR P00533 2/20 0.51
LMNA P02545 2/20 0.50
RAD52 P43351 1/20 0.49
HDAC1 Q13547 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC3 O15379 1/20 0.48
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.46
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069644 0.89 SMN1; SMN2 (0.73) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL12407210 0.86 SMN1; SMN2 (0.79) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL2072317 0.85 MEN1 (0.53) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL2069555 0.84 MEN1 (0.52) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL2069454 0.84 MEN1 (0.52) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL2070769 0.83 ALDH1A1 (0.52) SMN1; SMN2MEN1KMT2AMAPTKDR
SCHEMBL11654725 0.81 MAPT (0.59) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL2070558 0.81 MEN1 (0.49) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL2070063 0.81 KMT2A (0.49) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL3596486 0.80 MAPK1 (0.52) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906537-B2 Substituted p-diaminobenzene derivatives H. LUNDBECK A/S (DK) 2011-03-15 US disclosed
US-20060183791-A1 Substituted p-diaminobenzene derivatives H. LUNDBECK A/S (DK) 2006-08-17 US disclosed
CN-1761464-A Substituted p-diaminobenzene derivatives LUNDBECK & CO AS H (DK) 2006-04-19 CN disclosed
EP-1613303-A1 SUBSTITUTED P-DIAMINOBENZENE DERIVATIVES H. Lundbeck A/S (DK) 2006-01-11 EP disclosed
WO-2004082677-A1 SUBSTITUTED P-DIAMINOBENZENE DERIVATIVES H. LUNDBECK A/S (DK) 2004-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183791-A1 Substituted p-diaminobenzene derivatives ABCB1, UGT2B7, CYP2D6 SMN1; SMN2 2951/4885MEN1 1715/4885KMT2A 3706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.